Dr. Stevenson assists clients with patent drafting and prosecution in the U.S. and abroad, freedom-to-operate analyses, and intellectual property due diligence.
Following his doctoral studies, Dr. Stevenson conducted research in medicinal chemistry at Merck and Co., Inc. He designed and synthesized novel compounds targeting ion channels, g-protein-coupled receptors, and soluble enzymes as potential treatments for diabetes and pain. This work is the subject of numerous issued patents and patent applications.
Dr. Stevenson’s doctoral research in organic chemistry focused on the total synthesis of peloruside A as well as mechanistic and methodological investigations of the hydrolytic kinetic resolution of terminal epoxides. This work was presented at the Gordon Research Conference in Natural Products and published in peer-reviewed journals including Journal of the American Chemical Society, Angewandte Chemie, and Organic Syntheses.
Prior to joining Goodwin, Dr. Stevenson worked for open-innovation startup InnoCentive, Inc. His primary focus was reformulating clients’ long-standing scientific problems to make them amenable to crowdsourcing solutions from a global network of freelance scientists. He worked with clients across a broad range of industries including pharmaceuticals, biotechnology, agrochemicals, medical devices, cosmetics, paints and coatings, and flavors and fragrances.